Gene · 4065
Papers1,798
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,798
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Controlling Cell Trafficking: Addressing Failures in CAR T and NK Cell Therapy of Solid Tumours. | Cancers (Basel) | 2022 | 35205725 | PubTator, text mining | PubMed |
| New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy. | Cells | 2022 | 35203357 | PubTator, text mining | PubMed |
| Advantages, Factors, Obstacles, Potential Solutions, and Recent Advances of Fish Germ Cell Transplantation for Aquaculture-A Practical Review. | Animals (Basel) | 2022 | 35203131 | PubTator, text mining | PubMed |
| Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting. | Nat Cancer | 2022 | 35190724 | PubTator, text mining | PubMed |
| Clonal lineage tracing reveals shared origin of conventional and plasmacytoid dendritic cells. | Immunity | 2022 | 35180378 | PubTator, text mining | PubMed |
| New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells. | Int J Mol Sci | 2022 | 35163401 | PubTator, text mining | PubMed |
| Tumor-Derived Exosomes in Tumor-Induced Immune Suppression. | Int J Mol Sci | 2022 | 35163380 | PubTator, text mining | PubMed |
| Why Physical Activity Should Be Considered in Clinical Trials for COVID-19 Vaccines: A Focus on Risk Groups. | Int J Environ Res Public Health | 2022 | 35162875 | PubTator, text mining | PubMed |
| Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer. | Mol Cancer | 2022 | 35148751 | PubTator, text mining | PubMed |
| Chemo- and mechanosensing by dendritic cells facilitate antigen surveillance in the spleen. | Immunol Rev | 2022 | 35147233 | PubTator, text mining | PubMed |
| Distinct molecular phenotypes involving several human diseases are induced by IFN-λ3 and IFN-λ4 in monocyte-derived macrophages. | Genes Immun | 2022 | 35115664 | PubTator, text mining | PubMed |
| A model of preferential pairing between epithelial and dendritic cells in thymic antigen transfer. | Elife | 2022 | 35099391 | PubTator, text mining | PubMed |
| A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice. | Nat Commun | 2022 | 35087093 | PubTator, text mining | PubMed |
| Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis. | J Int Med Res | 2022 | 35086375 | PubTator, text mining | PubMed |
| Structural determinants of the dominant conformational epitopes of phospholipase A2 receptor in primary membranous nephropathy. | J Biol Chem | 2022 | 35065076 | PubTator, text mining | PubMed |
| Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa. | Nanomaterials (Basel) | 2022 | 35055244 | PubTator, text mining | PubMed |
| Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions. | Int J Mol Sci | 2022 | 35055096 | PubTator, text mining | PubMed |
| Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020. | Cancer Immunol Immunother | 2022 | 35034143 | PubTator, text mining | PubMed |
| Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. | Cell | 2022 | 35021063 | PubTator, text mining | PubMed |
| Critical parameters for design and development of multivalent nanoconstructs: recent trends. | Drug Deliv Transl Res | 2022 | 35013982 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4065/papers?page=16